These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 24406503

  • 1. IL-7 inhibits tumor growth by promoting T cell-mediated antitumor immunity in Meth A model.
    Tang JC, Shen GB, Wang SM, Wan YS, Wei YQ.
    Immunol Lett; 2014; 158(1-2):159-66. PubMed ID: 24406503
    [Abstract] [Full Text] [Related]

  • 2. Autoreactive and heat shock protein 60-recognizing CD4+ T-cells show antitumor activity against syngeneic fibrosarcoma.
    Harada M, Matsuzaki G, Yoshikai Y, Kobayashi N, Kurosawa S, Takimoto H, Nomoto K.
    Cancer Res; 1993 Jan 01; 53(1):106-11. PubMed ID: 8093229
    [Abstract] [Full Text] [Related]

  • 3. Hypothermic microenvironment plays a key role in tumor immune subversion.
    Du G, Liu Y, Li J, Liu W, Wang Y, Li H.
    Int Immunopharmacol; 2013 Oct 01; 17(2):245-53. PubMed ID: 23831011
    [Abstract] [Full Text] [Related]

  • 4. Synergistic effects of IL-12 and IL-18 in skewing tumor-reactive T-cell responses towards a type 1 pattern.
    Li Q, Carr AL, Donald EJ, Skitzki JJ, Okuyama R, Stoolman LM, Chang AE.
    Cancer Res; 2005 Feb 01; 65(3):1063-70. PubMed ID: 15705908
    [Abstract] [Full Text] [Related]

  • 5. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects.
    Osaki T, Péron JM, Cai Q, Okamura H, Robbins PD, Kurimoto M, Lotze MT, Tahara H.
    J Immunol; 1998 Feb 15; 160(4):1742-9. PubMed ID: 9469432
    [Abstract] [Full Text] [Related]

  • 6. All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells.
    Van YH, Lee WH, Ortiz S, Lee MH, Qin HJ, Liu CP.
    Diabetes; 2009 Jan 15; 58(1):146-55. PubMed ID: 18984738
    [Abstract] [Full Text] [Related]

  • 7. Naloxone can improve the anti-tumor immunity by reducing the CD4+CD25+Foxp3+ regulatory T cells in BALB/c mice.
    Molla Hassan AT, Hassan ZM, Moazzeni SM, Mostafaie A, Shahabi S, Ebtekar M, Hashemi SM.
    Int Immunopharmacol; 2009 Nov 15; 9(12):1381-6. PubMed ID: 19706340
    [Abstract] [Full Text] [Related]

  • 8. Transforming growth factor beta 1 costimulated growth and regulatory function of staphylococcal enterotoxin B-responsive CD8+ T cells.
    Rich S, Seelig M, Lee HM, Lin J.
    J Immunol; 1995 Jul 15; 155(2):609-18. PubMed ID: 7608539
    [Abstract] [Full Text] [Related]

  • 9. Intratumoral interleukin-21 increases antitumor immunity, tumor-infiltrating CD8+ T-cell density and activity, and enlarges draining lymph nodes.
    Søndergaard H, Galsgaard ED, Bartholomaeussen M, Straten PT, Odum N, Skak K.
    J Immunother; 2010 Apr 15; 33(3):236-49. PubMed ID: 20445344
    [Abstract] [Full Text] [Related]

  • 10. IL-17/IFN-γ double producing CD8+ T (Tc17/IFN-γ) cells: a novel cytotoxic T-cell subset converted from Tc17 cells by IL-12.
    Tajima M, Wakita D, Satoh T, Kitamura H, Nishimura T.
    Int Immunol; 2011 Dec 15; 23(12):751-9. PubMed ID: 22039016
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of anti-cancer and immunomodulatory effects of carnosol in a Balb/c WEHI-164 fibrosarcoma model.
    Rahnama M, Mahmoudi M, Zamani Taghizadeh Rabe S, Balali-Mood M, Karimi G, Tabasi N, Riahi-Zanjani B.
    J Immunotoxicol; 2015 Dec 15; 12(3):231-8. PubMed ID: 25027673
    [Abstract] [Full Text] [Related]

  • 12. Influence of polysaccharide fractions isolated from Caltha palustris L. on the cellular immune response in collagen-induced arthritis (CIA) in mice. A comparison with methotrexate.
    Suszko A, Obmińska-Mrukowicz B.
    J Ethnopharmacol; 2013 Jan 09; 145(1):109-17. PubMed ID: 23123796
    [Abstract] [Full Text] [Related]

  • 13. Co-delivery of T helper 1-biasing cytokine genes enhances the efficacy of gene gun immunization of mice: studies with the model tumor antigen beta-galactosidase and the BALB/c Meth A p53 tumor-specific antigen.
    Tüting T, Gambotto A, Robbins PD, Storkus WJ, DeLeo AB.
    Gene Ther; 1999 Apr 09; 6(4):629-36. PubMed ID: 10476222
    [Abstract] [Full Text] [Related]

  • 14. Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells.
    Matesic D, Valujskikh A, Pearlman E, Higgins AW, Gilliam AC, Heeger PS.
    J Immunol; 1998 Nov 15; 161(10):5236-44. PubMed ID: 9820495
    [Abstract] [Full Text] [Related]

  • 15. Synergistic enhancement of antitumor immunity with adoptively transferred tumor-specific CD4+ and CD8+ T cells and intratumoral lymphotactin transgene expression.
    Huang H, Li F, Gordon JR, Xiang J.
    Cancer Res; 2002 Apr 01; 62(7):2043-51. PubMed ID: 11929823
    [Abstract] [Full Text] [Related]

  • 16. Differential effects of IL-12 receptor blockade with IL-12 p40 homodimer on the induction of CD4+ and CD8+ IFN-gamma-producing cells.
    Piccotti JR, Chan SY, Li K, Eichwald EJ, Bishop DK.
    J Immunol; 1997 Jan 15; 158(2):643-8. PubMed ID: 8992979
    [Abstract] [Full Text] [Related]

  • 17. Synergistic effects of IL-7 and IL-12 on human T cell activation.
    Mehrotra PT, Grant AJ, Siegel JP.
    J Immunol; 1995 May 15; 154(10):5093-102. PubMed ID: 7730615
    [Abstract] [Full Text] [Related]

  • 18. Arteether exerts antitumor activity and reduces CD4+CD25+FOXP3+ T-reg cells in vivo.
    Azimi Mohamadabadi M, Hassan ZM, Zavaran Hosseini A, Gholamzad M, Noori S, Mahdavi M, Maroof H.
    Iran J Immunol; 2013 Sep 15; 10(3):139-49. PubMed ID: 24076591
    [Abstract] [Full Text] [Related]

  • 19. Repeated restraint stress impairs the antitumor T cell response through its suppressive effect on Th1-type CD4+ T cells.
    Li T, Harada M, Tamada K, Abe K, Nomoto K.
    Anticancer Res; 1997 Sep 15; 17(6D):4259-68. PubMed ID: 9494518
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-7 enhances the in vivo anti-tumor activity of tumor-reactive CD8+ T cells with induction of IFN-gamma in a murine breast cancer model.
    Yuan CH, Yang XQ, Zhu CL, Liu SP, Wang BC, Wang FB.
    Asian Pac J Cancer Prev; 2014 Sep 15; 15(1):265-71. PubMed ID: 24528037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.